FINAL program

A printer friendly version can be downloaded HERE.

Sunday, September 3rd


15:00  

Registration

17:00

Opening cerimony

Chair: Erika Del Grosso

17:30

 PL1 From Metabolism to Metabolomics – an analytical journey.

Serge Rudaz - University of Geneva (Switzerland)

18:40 

-Trio Artemide - concert

19:30 

Welcome cocktails

Monday, September 4th 


Pharmaceutical Analysis I

Chairs: Laura Mercolini and Bezhan Chankvetadze 


9:30 

KN1 Application of polysaccharide-based chiral columns to enantioselective bioanalysis of psychotropic compounds.

Bezhan Chankvetadze - University of Tbilisi (Georgia)

10:00 

OC1 Surface plasmon resonance and grating-coupled interferometry to investigate interactions with GPR17 membrane receptor.

Francesca Rinaldi - University of Pavia (Italy)

10:20 

FC1 Accelerating Oligonucleotide Research Using Novel Bioinert LC, QTOF and TQ LC-MS.

Paolo Redegalli - Shimadzu (Italy)

10:30

Coffee break


Pharmaceutical Analysis II

Chairs: Roccaldo Sardella and István Ilisz 


11:00

KN2 Advanced analytical tools in pharmaceutical analysis. 1D and 2D LC-MS techniques applied in biomedical sciences.

István Ilisz - University of Szeged (Hungary)

11:30

OC2 Rethinking a sample preparation procedure overlooked for too long.

Luca Regazzoni - Università degli studi di Milano (Italy)

11:50

OC3 Can purified water impact your LC-MS analyses of pharmaceutical molecules?

Graziano Marcer - Merck Life Science (Italy)


12:10 

Lunch


13:15

Poster session I


Bioanalysis in Drug Discovery & Development

Chairs: Angela De Simone and Laura Goracci 


14:30

KN3 Untargeted Lipidomics in early drug discovery: aims and computer-aided workflows.

Laura Goracci - University of Perugia (Italy)

15:00

OC4 LC-MS/MS and IC-LC-MS/MS methods for the quantification of NBE and ADC in preclinical studies.

Ilse Maria Luce De Salve - Merck RBM Colleretto Giacosa (Italy)

15:20

OC5 Integrated mass spectrometry-based strategy to evaluate metabolic stability, pharmacokinetics, and pharmacodynamics: a case study on novel soluble epoxide hydrolase inhibitors.

Manuela Giovanna Basilicata - University of Salerno (Italy)

15:40

OC6 Mass Spectrometry Imaging as support to novel CB-2 agonist development: simultaneous spatial detection of multiple neurotransmitters in a model of cognitive impairment.

Emanuela Salviati - University of Salerno (Italy)


16:00

Coffee break


Food Analysis

Chairs: Jean Daniel Coisson and Chiara Cordero


16:20

KN4 Comprehensive two-dimensional gas chromatography a gestalt technique in food metabolomics.

Chiara Cordero - University of Turin (Italy)

16:50

OC7 A new millifluidic-based gastrointestinal model to study bioaccessibility and cytotoxicity of bioactive compounds.

Raffaella Colombo - University of Pavia (Italy)

17:10

OC8 Integrated analytical approaches for the characterization of nutraceutical bioactives in microalgae.

Serena Montanari - Alma Mater Studiorum University of Bologna (Italy)

Tuesday, September 5th

Chair: Ersilia De Lorenzi


9:15

PL2 Molecularly imprinted polymers as versatile abiotic receptors in bioanalysis.

Börje Sellergren - Malmö University (Sweden)


Clinical and Biomedical Analysis

Chairs: Caterina Temporini and Myriam Taverna


10:00

KN5 Microfluidic and electrophoretic approaches to address the challenges generated by the exploration of extracellular vesicles for diagnostic or therapeutic applications.

Myriam Taverna - University of Paris-Saclay , IGPS,  Orsay (France)

10:30

OC9 Lipidomics of neuroblastoma cells under Aß1-42 toxic insult

Lara Davani - Alma Mater Studiorum University of Bologna (Italy)

10:50

FC2 Glycan specific MIPs for cancer associated biomarkers.

Cecilia Contardi - University of Pavia (Italy)

11:00

FC3 Comprehensive characterization of protein therapeutics using electron activated dissociation (EAD)

Gaia Cermenati - DaSP S.r.l. Milan (Italy)


11:10

Coffee break


Protein Analysis

Chairs: Francesco Epifano and Jose Luis Capelo


11:30

KN6 Prescriptomics: what is it expecting ahead?

Jose Luis Capelo - University of Lisbon (Portugal)


12:00

OC10 Mpro protease  (SARS-CoV-2) covalent inhibitors identification from an anthocyanin-rich blueberry extract using an OMICS-based analytical platform.

Alessandra Anna Altomare - Università degli studi di Milano (Italy)


12:20

OC11 Elucidation of the anti-inflammatory and antioxidant activities of 5-(3'-4'-dihydrophenyl)-ƴ-valerolactone, the main metabolite of a standardized grapeseed pacs extract through a proteomic approach.

Giovanna Baron - Università degli studi di Milano (Italy)


12:40

Lunch


14:00

Poster session II


Metabolomics and Lipidomics

Chairs: Giancarlo Aldini and Antonia García 


15:00

 KN7 Multiplatform strategies for the study of microbial metabolites by MS-based metabolomics.

Antonia García - University San Pablo, Madrid (Spain)

15:30 

OC12 Metaproteomics and metabolomics investigation of microbiome alterations in pediatric obese patients subjected to a dietary intervention with Mediterranean diet.

Marcello Manfredi - University of Piemonte Orientale

15:50 

OC13 Sub-5 min 4D-Lipidomics: A proof of concept.

Fabrizio Merciai - University of Salerno (Italy)

16:10

 FC4 Investigating the metabolomic network in patients with diabetic kidney disease.

Marta Nugnes - Alma Mater Studiorum University of Bologna (Italy)


16:20 

Coffee break


Drug Product Analysis 

Chairs: Eduardo Maria Sommella and Simone Nicolardi


16:40

KN8 Application of MALDI FT-ICR MS in the Development of Glycoengineered Bacterial E. coli Vaccines.

Simone Nicolardi - Leiden University Medical Center (LUMC) (Netherlands)

17:10

OC14 Application of ion chromatography to analyse pharmaceutical formulations.

Erwin Adams - University of Leuven (Belgium)

17:30

FC5 Chemometric tools for photostability testing of tamoxifen in the oral formulation and stabilization strategies.

Martina Chieffallo - University of Calabria (Italy)

17:40

OC15 ICH Q2(R2) and Q14: the new frontiers.

Dina Cavallo - PRC TICINUM LAB Novara (Italy)


20:30

Social dinner

Wednesday, September 6th

Chair: Michele De Luca


9:00

 PL3 Chemometric-based strategies for metabolomics and pharmaceutical analysis

Federico Marini - Sapienza University of Rome (Italy)


Natural Products I

Chairs: Vincenza Andrisano and Clara Grosso


9:45

KN9 Neuroprotective assessment of medicinal plant extracts.

Clara Grosso - Polytechnic Institute of Porto (Portugal)

10:15

OC16 Targeting PPAR-α and PPAR-γ through AS-MS approach: two-dimensional chromatography for the affinity screening of bioactive components in natural products.

Giulia De Soricellis - University of Pavia (Italy)

10:35

OC17 Use of natural ingredients with antiviral activity in the production of nasal and oro-pharyngeal sprays for the prevention of flu syndrome resulting from Sars Cov2: the cross-border 'SPRAY' project.

Luigi Panza - Consorzio IBIS Innovative BIo-based and Sustainable products and processes Novara (Italy)

10:55

FC6 Polyphenols from Cannabis sativa L.: new methods for their extraction, analysis, and evaluation of their antiproliferative activity against colorectal cancer.

Clarissa Caroli - University of Modena and Reggio Emilia (Italy)


11:05

Coffee break


Natural Products II 

Chairs: Federica Pellati and Dan Stærk


11:25

KN10 Bioactivity-correlated analytical techniques used for studying bioactive drug leads in desert- loving Eremophila spp.

Dan Stærk - University of Copenhagen (Denmark)

11:55

OC18 Optimized strategy for the isolation of Elenolic Acid (EA) from Olea europea L. leaf.

Serena Fiorito - University of Chieti-Pescara (Italy)

12:15

FC7 Multidimensional chromatographic fingerprinting combined with chemometrics for the identification of regulated plants in suspicious plant food supplements.

Surbhi Ranjan - University of Leuven (Belgium)


12:25

 Best posters awards 


12:45

Closing remarks


13:00

Farewell lunch